RhumbLine Advisers’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.52M | Buy |
65,556
+2,017
| +3% | +$139K | ﹤0.01% | 1464 |
|
2025
Q1 | $4.41M | Buy |
63,539
+5,898
| +10% | +$410K | ﹤0.01% | 1421 |
|
2024
Q4 | $4.96M | Sell |
57,641
-5,598
| -9% | -$482K | ﹤0.01% | 1427 |
|
2024
Q3 | $7.53M | Buy |
63,239
+2,265
| +4% | +$270K | 0.01% | 1204 |
|
2024
Q2 | $8.7M | Buy |
60,974
+270
| +0.4% | +$38.5K | 0.01% | 1096 |
|
2024
Q1 | $7.79M | Buy |
60,704
+1,851
| +3% | +$238K | 0.01% | 1171 |
|
2023
Q4 | $6.09M | Sell |
58,853
-469
| -0.8% | -$48.5K | 0.01% | 1302 |
|
2023
Q3 | $5.39M | Buy |
59,322
+5,780
| +11% | +$526K | 0.01% | 1288 |
|
2023
Q2 | $4.33M | Buy |
+53,542
| New | +$4.33M | ﹤0.01% | 1463 |
|
2021
Q4 | – | Sell |
-4,180
| Closed | -$201K | – | 3018 |
|
2021
Q3 | $201K | Buy |
+4,180
| New | +$201K | ﹤0.01% | 2914 |
|
2016
Q3 | – | Sell |
-41,600
| Closed | -$1.12M | – | 2916 |
|
2016
Q2 | $1.12M | Hold |
41,600
| – | – | ﹤0.01% | 1714 |
|
2016
Q1 | $1.13M | Hold |
41,600
| – | – | ﹤0.01% | 1715 |
|
2015
Q4 | $1.21M | Buy |
41,600
+2,200
| +6% | +$63.9K | ﹤0.01% | 1686 |
|
2015
Q3 | $1.07M | Buy |
39,400
+1,200
| +3% | +$32.6K | ﹤0.01% | 1721 |
|
2015
Q2 | $1.05M | Sell |
38,200
-14,800
| -28% | -$405K | ﹤0.01% | 1836 |
|
2015
Q1 | $1.42M | Sell |
53,000
-200
| -0.4% | -$5.34K | ﹤0.01% | 1647 |
|
2014
Q4 | $1.13M | Sell |
53,200
-6,600
| -11% | -$140K | ﹤0.01% | 1721 |
|
2014
Q3 | $1.42M | Hold |
59,800
| – | – | ﹤0.01% | 1535 |
|
2014
Q2 | $1.38M | Hold |
59,800
| – | – | ﹤0.01% | 1621 |
|
2014
Q1 | $1.37M | Sell |
59,800
-1,000
| -2% | -$22.8K | ﹤0.01% | 1599 |
|
2013
Q4 | $1.12M | Buy |
60,800
+33,000
| +119% | +$610K | ﹤0.01% | 1735 |
|
2013
Q3 | $470K | Buy |
27,800
+10,000
| +56% | +$169K | ﹤0.01% | 2249 |
|
2013
Q2 | $276K | Buy |
+17,800
| New | +$276K | ﹤0.01% | 2720 |
|